It has been well established that estrogen stimulates growth of the mammary glands in various animals and that it is a primary stimulator for the mammary duct growth in mice (Turner et al., 1932; Reece, 1958; Linzell, 1959) . On the other hand, androgen has been considered as an inhibitor of the normal development and function of the mammary gland (Hoshino, 1965; Ben-David et al., 1965; Turkington and Topper, 1967) .
The interference by steroids, however, with the estrogen stimulation to the mammary gland has not been extensively investigated The mounts were kept in the Bouin solution for a few days for staining and fixing. The area showing the distribution of ductal system was traced under the dissecting microscope by pricking through a sheet of polyethylene which was put over the mount. The pattern of mammary gland traced on the polyethylene sheet was reprinted on a sheet of paper and the area of mammary gland was measured by a planimeter or the electronic area meter devised by Hakata and Kurokawa (1967) . The ratio of mammary gland against body weight, represented by 100times the area of ductal system in terms of square millimeter per gram body weight, was used as a criterion of the mammary response.
The assays were usually run in 6 groups. The The compounds tested are 5a-androstan-17ƒÀ- There is a fact that the potent mammary growth inhibitors(I, IV, VIII, IX and X) commonly possess a high myotropic activity (Hilgar and Hummel, 1964) , suggesting that there is no direct correlation between the androgenic potency and mammary growth inhibiting activity of steroids. The physiological significance of the steroid inhibition to the estrogen-causing mammary duct extension is not clearly understood, but it is shown that there are many similarities between the effects of steroids on the normal mammary gland and those on the hormoneresponsive mammary tumor in experimental animals. Huggins and Mainzer(1957) , Huggins et al.(1956) indicated that the growth rate of mammary tumor in the Sprague-Dawley rat is stimulated by estrogen or progestin and is retarded by androstanes. It is noteworthy that the androstanes with mammary growth inhibiting activity have been known as the potent inhibitors of mammary tumor growth (Huggins and Mainzer, 1957) and of glycine-2-C14 uptake into the protein of the tumor (Abe et al. 1962; Rooks et al., 1963) , in the system of which 19-nortestosterone, norethisterone, progesterone and MER-25 have no inhibiting activity. Androgen has been widely accepted as an inhibitor of mammary tumor in animals and humans, although its mode of action is not well understood (Dunning, 1960; Glenn et al., 1960; Kim, 1965) .
From these findings, it may be considered that the anti-mammary test described here is of value for the evaluation of anti-estrogenic activity of steroidal compounds. It is believed, however, that ovarian hormones act synergistically with antrior pituitray hormones HORI AND MIYAKE Endocrinol.
Japon. Dec. 1968 (Lyons et al., 1957; Kim, 1965; Fruth, 1965) although the role of pituitary factors affecting mammary development was still uncertain. Thus, whether the mammary growth inhibitor directly acts on the ductal cell level or on the secretion of any mammary growth-promoting factors from the pituitary requires further investigation.
